Dr Nicola Hamilton-Whitaker PhD
I lead the Hamilton Lab group, which is interested in brain function in white matter diseases such as Multiple Sclerosis, and Small Vessel Disease, which both lead to severe demyelination. We study the interactions between neurons, glial cells, immune cells and the vasculature using in vivo disease models, along with techniques such as electrophysiology (patch-clamping and compound action potential recording), confocal and 2-photon imaging, immunolabelling and electron microscopy. Using these techniques, we can combine our interests in studying receptor-mediated cellular communication with morphology, to determine how receptor activity regulates cell function.
Please see my Research Staff Profile for more detail.
- Madry, et al., 2018. Effects of the ecto-ATPase apyrase on microglial ramification and surveillance reflect cell depolarization not ATP depletion. Proc. Nat. Acad. Sciences.
- Hamilton, et al., 2017. Endogenous GABA controls oligodendrocyte lineage cell number, myelination and CNS internode length. Glia.
- Hamilton, et al., 2016. Proton-gated Ca2+-permeable TRP channels mediate myelin damage in conditions mimicking ischaemia. Nature.
- Dr Catherine Hall, University of Sussed
- Professor Kenneth Smith, University College London
- Dr Diana Cash, King's College London
- Professor David Attwell, University College London